Telmita Plus 40/12.5 mg Tablets

Adult dose

For adults, if blood pressure is not controlled with telmisartan alone, take 1 tablet daily with water, regardless of meals. Before switching to this fixed-dose combination, it is recommended to adjust the doses of each component individually according to the patient's needs. Patients with renal impairment: There is no need for dose adjustment in mild to moderate renal impairment, but this medication should not be administered to patients with severe renal impairment (creatinine clearance < 30 mL/min).

Child dose

This medication should not be administered to children under 18 years of age as its safety and efficacy have not been established.

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters; therefore, it should be stopped immediately upon confirmation of pregnancy. Patients with allergies to the ingredients of this medication or with certain liver or kidney diseases should not use it. Elderly patients or those with high potassium levels in the blood, or those with impaired liver function should use this medication cautiously. It may increase the risk of skin cancer; thus, sun exposure should be avoided, and skin condition should be monitored regularly. Since this medication lowers blood pressure, dizziness or symptoms of low blood pressure may occur, so caution is needed when driving or operating machinery. During the use of this medication, regular checks of electrolyte levels in the blood and kidney function should be conducted to ensure no abnormalities. Additionally, since interactions may occur when taking this medication with other antihypertensives, diuretics, or potassium supplements, consultation with a physician is advised. In cases of overdose, symptoms such as low blood pressure, cardiac arrhythmias, and electrolyte imbalances may occur. In such cases, immediate medical attention should be sought. This medication is not recommended for children under 18 years of age as its safety and efficacy have not been established.

Serious side effects

Urticaria, angioedema, angioedema (including fatal outcomes), vasculitis, necrotizing vasculitis, anaphylactic reaction, chest tightness, difficulty breathing, dyspnea, pulmonary edema, acute respiratory distress syndrome (ARDS), pulmonary inflammation, severe swelling (edema), edema associated with increased blood pressure, jaundice, liver function disorders/liver damage, extreme fatigue, acute renal failure, anuria, severe edema,

Mild side effects

• Bronchitis
• pharyngitis
• sinusitis
• hypokalemia
• hyperuricemia
• hyponatremia
• anxiety
• depression
• insomnia
• sleep disturbances

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is advisable to keep the storage temperature between 1 and 30 degrees Celsius. This will help maintain the effectiveness of the medication and prevent degradation.

Appearance

Oval-shaped tablets consisting of two layers in white/pink, with the white layer possibly having pink specks.

Package unit

30 tablets (10 tablets/ PTP×3)